Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival.
Benza RL, Barst RJ, Galie N, Frost A, Girgis RE, Highland KB, Strange C, Black CM, Badesch DB, Rubin L, Fleming TR, Naeije R.
Chest. 2008 Oct;134(4):775-82. Epub 2008 Jul 14. Erratum in: Chest. 2009 Apr;135(4):1114. PMID: 18625676 [PubMed - indexed for MEDLINE]Related articlesFree article